The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
Stefan Flasche, Mark Jit, Isabel Rodríguez-Barraquer, Laurent Coudeville, Mario Recker, Katia Koelle, George Milne, Thomas J. Hladish, T. Alex Perkins, Derek A.T. Cummings, Ilaria Dorigatti, Daniel J. Laydon, Guido España, Joel Kelso, Ira Longini, Jose Lourenco, Carl A.B. Pearson, Robert C. Reiner, Luis Mier-y-Terán-Romero, Kirsten VanniceNeil Ferguson
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study'. Together they form a unique fingerprint.